BioPharmSignal logoBioPharmSignal

Biotech News

Hyperfine to Join Russell 2000® and Russell 3000® Indexes

Hyperfine (HYPR)HyperfineFDA / regulatory

GUILFORD, Conn. --(BUSINESS WIRE)--May 26, 2026-- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system— today announced that Hyperfine is expected to

Open original release

Related news

HYPRHyperfine2026-04-09 12:15 EST

Hyperfine Receives CE and UKCA Marks for Next-Generation Swoop® System and Latest Advancement in Optive AI™ Software

HYPRHyperfine2026-03-18 20:05 EST

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

AORTArtivion2026-04-07 11:00 EST

Artivion Announces U.S. FDA Approval of the NEXUS® Aortic Arch System

BSXBoston Scientific2026-03-30 10:45 EST

Boston Scientific receives FDA clearance for the Asurys™ Fluid Management System

ICCMIceCure Medical2026-07-06 12:11 EST

IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA Clearance for Breast Cancer

ICCMIceCure Medical2026-06-17 12:25 EST

IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance

DNLIDenali Therapeutics2026-03-25 15:50 EST

Denali Therapeutics Announces U.S. FDA Approval of AVLAYAH™ (tividenofusp alfa-eknm) for Treatment of Hunter Syndrome (MPS II)

EHCEncompass Health Corporation2026-07-23 12:00 EST

Encompass Health increases and declares dividend on common stock

DNLIDenali Therapeutics2026-05-21 22:00 EST

Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease

SGHTSight Sciences2026-05-06 20:05 EST

Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance

View all latest news

Hyperfine

Hyperfine is a medical device company focused on portable MRI systems and point-of-care imaging. Its business is centered on making advanced imaging more accessible outside traditional radiology settings.

Recent company news

HYPRHyperfine2026-07-01 12:15 EST

Hyperfine Announces European Launch of Next-Generation Swoop® System

HYPRHyperfine2026-06-22 12:15 EST

Hyperfine Forms Global Neurosurgery Advisory Council to Support Expansion of Portable MRI in Neurosurgical Care

HYPRHyperfine2026-06-18 12:15 EST

Hyperfine Swoop® System Scan Volume in the United States Hits Record Milestones Across Multiple Sites of Care

HYPRHyperfine2026-05-26 12:15 EST

Hyperfine to Join Russell 2000® and Russell 3000® Indexes

HYPRHyperfine2026-05-22 12:15 EST

Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments

Stock data

Close
0.96 USD
Market cap
148.91M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States